Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 104,177 | 79,945 | 58,927 | 26,288 | 9,297 |
| Operating Income | -104,177 | -79,945 | -58,927 | -26,288 | -9,297 |
| Other Income | 17,696 | 10,811 | 3,602 | -6 | -39 |
| Pre-tax Income | -86,481 | -69,134 | -55,325 | -26,294 | -9,336 |
| Net Income Continuous | -86,481 | -69,134 | -55,325 | -26,294 | -9,336 |
| Net Income | $-86,481 | $-69,134 | $-55,325 | $-26,294 | $-9,336 |
| EPS Basic Total Ops | -1.51 | -1.62 | -1.32 | -1.91 | -6.05 |
| EPS Basic Continuous Ops | -1.51 | -1.62 | -1.32 | -1.91 | -6.05 |
| EPS Diluted Total Ops | -1.51 | -1.62 | -1.32 | -1.91 | -6.05 |
| EPS Diluted Continuous Ops | -1.51 | -1.62 | -1.32 | -1.91 | -6.05 |
| EPS Diluted Before Non-Recurring Items | -1.51 | -1.62 | -1.32 | -1.91 | N/A |
| EBITDA(a) | $-103,658 | $-79,588 | $-58,631 | $-26,148 | $-9,250 |